A Prospective, Open-label, Single-center Study of the Atia™ AVL200 Modular Intraocular Lens System for Treatment of Cataract and Presbyopia
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study is to evaluate the performance of the AVL200 IOL in terms of visual function improvement over a range of focal points. Participants meeting eligibility criteria will undergo cataract surgery with implantation of the AVL200 intraocular lens (IOL), then be followed through 1 year postoperatively. Postoperative assessments include safety and visual function.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:
• Visually significant cataract
• Best corrected distance visual acuity between 20/40 and 20/200
• Potential distance visual acuity of 20/32 or better
• Corneal astigmatism ≤ 1.5 diopters
Locations
Other Locations
India
Dr Agarwal's Eye Hospital
RECRUITING
Chennai
Contact Information
Primary
Melissa Guerrero
melissa@atiavision.com
408-560-3339
Backup
Preethi Thiagarajan, OD
preethi@atiavision.com
Time Frame
Start Date: 2022-07-25
Estimated Completion Date: 2026-01-31
Participants
Target number of participants: 60
Treatments
Experimental: AVL200 IOL
The AVL200 is a modular fluid-filled, shape-changing intraocular lens (IOL) designed to restore visual function across a range of focal points
Related Therapeutic Areas
Sponsors
Leads: Atia Vision